• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

SoundHealth Launches First-Ever Real-Time Personalized Allergy Forecast

by Syed Hamza Sohail 09/17/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– SoundHealth, Inc. (“SoundHealth”), a medical technology company harnessing the power of artificial intelligence and medical science to improve patient outcomes, today introduced the first-ever personalized allergy forecast based on a person’s facial anatomy and their surrounding environment. 

– The SoundHealth SONU app uses patented AI algorithms to scan a user’s face and produce a real-time, personalized forecast of their allergy symptoms based on their location.

SONUCast: The World’s First AI-Powered Wearable for Allergy Forecasting and Treatment

SONUCast is the first system to pair with an FDA-approved wearable device to treat symptoms of allergic rhinitis, including nasal congestion, rhinorrhea (runny nose), and nasal itching caused by airborne particles in the nasal cavity. The wearable utilizes advanced Acoustic Resonance Therapy (ART) to deliver a non-pharmaceutical treatment for rhinitis, providing relief that is comparable to or better than nasal corticosteroids, without known side effects.

Powered by SoundHealth’s proprietary AI/ML algorithms, SONUCast can estimate internal sinonasal dimensions with a margin of error of less than 5% compared to CT scans. This technology enables real-time computational modeling and personalized predictions of nasal allergies. Once users scan their faces, SONUCast instantly generates a personalized allergy forecast based on their location, anywhere in the world.

SONUCast’s AI, trained on data from thousands of human subjects and hundreds of CT scans, is the first system designed for both allergy forecasting and ART. The wearable SONU band, approved by the FDA, provides a groundbreaking non-invasive solution for rhinitis treatment.

SoundHealth, the company behind SONUCast, is a medical technology firm focused on improving respiratory health through the power of artificial intelligence and medical science. The team at SoundHealth consists of experienced medical professionals, data scientists, and engineers committed to advancing healthcare. Investors in SoundHealth include Moai Capital, J4 Ventures, TeleSoft Partners, Tau Ventures, TechU Ventures, and Rhythm Venture Capital.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |